Birdwatch Note
2024-12-02 19:19:18 UTC - NOT_MISLEADING
The post expresses and documents a view that regards Ozempic as a dangerous therapy and offers alternatives. As such it is an opiniated advocacy thread with inherit biases. There is nothing wrong with presenting views like this and no fact check is needed.
Written by DD9213B8CC8819C535CE70E94383CAC07F8847C4029D54CE857962A1F99BF03B
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1863561702358352157
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1863664255175889211
- noteId - 1863664255175889211
- participantId -
- noteAuthorParticipantId - DD9213B8CC8819C535CE70E94383CAC07F8847C4029D54CE857962A1F99BF03B Participant Details
- createdAtMillis - 1733167158299
- tweetId - 1863561702358352157
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 1
- trustworthySources - 0
- summary
- The post expresses and documents a view that regards Ozempic as a dangerous therapy and offers alternatives. As such it is an opiniated advocacy thread with inherit biases. There is nothing wrong with presenting views like this and no fact check is needed.
Note Ratings
rated at | rated by | |
2024-12-02 17:07:14 -0600 | Rating Details | |
2024-12-02 17:07:08 -0600 | Rating Details | |
2024-12-02 16:11:36 -0600 | Rating Details | |
2024-12-02 16:08:06 -0600 | Rating Details | |
2024-12-02 16:06:22 -0600 | Rating Details | |
2024-12-02 15:51:23 -0600 | Rating Details | |
2024-12-02 15:49:44 -0600 | Rating Details | |
2024-12-02 15:47:38 -0600 | Rating Details | |
2024-12-02 15:44:20 -0600 | Rating Details | |
2024-12-02 15:38:06 -0600 | Rating Details | |
2024-12-02 15:32:57 -0600 | Rating Details | |
2024-12-02 15:24:26 -0600 | Rating Details | |
2024-12-02 15:20:09 -0600 | Rating Details | |
2024-12-02 15:00:35 -0600 | Rating Details | |
2024-12-02 14:58:23 -0600 | Rating Details | |
2024-12-02 14:29:41 -0600 | Rating Details | |
2024-12-02 14:27:18 -0600 | Rating Details | |
2024-12-02 14:26:33 -0600 | Rating Details | |
2024-12-02 14:12:54 -0600 | Rating Details | |
2024-12-02 13:48:07 -0600 | Rating Details | |
2024-12-02 13:39:03 -0600 | Rating Details | |
2024-12-02 13:33:59 -0600 | Rating Details | |
2024-12-02 13:27:26 -0600 | Rating Details | |
2024-12-02 13:27:25 -0600 | Rating Details | |
2024-12-02 13:26:57 -0600 | Rating Details | |
2024-12-02 13:24:03 -0600 | Rating Details | |
2024-12-03 14:08:35 -0600 | Rating Details | |
2024-12-03 13:57:21 -0600 | Rating Details | |
2024-12-03 07:02:38 -0600 | Rating Details | |
2024-12-03 04:23:47 -0600 | Rating Details | |
2024-12-02 22:58:32 -0600 | Rating Details | |
2024-12-02 22:08:48 -0600 | Rating Details | |
2024-12-02 20:42:18 -0600 | Rating Details | |
2024-12-02 19:53:24 -0600 | Rating Details | |
2024-12-07 13:03:08 -0600 | Rating Details | |
2024-12-03 04:36:58 -0600 | Rating Details | |
2024-12-03 02:02:43 -0600 | Rating Details | |
2024-12-02 22:18:54 -0600 | Rating Details | |
2024-12-02 21:08:13 -0600 | Rating Details | |
2024-12-02 18:33:32 -0600 | Rating Details | |
2024-12-02 16:36:57 -0600 | Rating Details | |
2024-12-02 16:34:53 -0600 | Rating Details | |
2024-12-02 15:52:18 -0600 | Rating Details | |
2024-12-02 15:15:03 -0600 | Rating Details | |
2024-12-02 15:09:02 -0600 | Rating Details | |
2024-12-02 14:55:39 -0600 | Rating Details | |
2024-12-02 14:34:38 -0600 | Rating Details | |
2024-12-02 14:01:23 -0600 | Rating Details | |
2024-12-02 13:51:23 -0600 | Rating Details | |
2024-12-02 13:44:16 -0600 | Rating Details | |
2024-12-02 18:37:54 -0600 | Rating Details | |
2024-12-02 17:51:13 -0600 | Rating Details | |
2024-12-02 17:39:59 -0600 | Rating Details | |
2024-12-02 17:35:43 -0600 | Rating Details | |
2024-12-02 17:08:34 -0600 | Rating Details | |
2024-12-02 17:07:15 -0600 | Rating Details | |
2024-12-02 17:00:04 -0600 | Rating Details | |
2024-12-02 16:25:56 -0600 | Rating Details | |
2024-12-02 16:10:50 -0600 | Rating Details | |
2024-12-02 16:02:59 -0600 | Rating Details | |
2024-12-02 15:15:27 -0600 | Rating Details | |
2024-12-02 15:08:40 -0600 | Rating Details | |
2024-12-02 14:58:16 -0600 | Rating Details | |
2024-12-02 14:51:43 -0600 | Rating Details | |
2024-12-02 14:43:08 -0600 | Rating Details | |
2024-12-02 14:32:07 -0600 | Rating Details | |
2024-12-02 14:03:27 -0600 | Rating Details | |
2024-12-02 13:32:48 -0600 | Rating Details |